Temtum (TEM) news

Tempus AI launches effort to build 100,000 whole-genome dataset linked to clinical outcomes

Tempus AI wins up to $9.5 million ARPA-H ADVOCATE award for autonomous heart failure agent

The Cure for Cancer is Becoming an Investable Opportunity: Analyst Sees $600 Million for Tempus AI

Breakthrough in "Personalized Cancer Vaccines"! "Tumor Sequencing" Becomes a Hot Topic

Dow Jones Top Company Headlines at 3 PM ET: NHTSA Opens Probe Into Tesla's Cybercab Rollout | Volkswagen's ...

Dow Jones Top Company Headlines at 1 PM ET: NHTSA Opens Probe Into Tesla's Cybercab Rollout | Drugmakers ...

Dow Jones Top Company Headlines at 11 AM ET: NHTSA Opens Probe Into Tesla's Cybercab Rollout | Drugmakers ...

Dow Jones Top Company Headlines at 9 AM ET: EQT to Buy Insurance Broker McGill in $2 Billion Deal | Tesla-Challenging ...

Tempus AI CEO Lefkofsky to speak at Morgan Stanley Global Healthcare Conference

Tempus AI CEO, Chairman Eric Lefkofsky reports disposal of common shares worth $12.43 million

Tempus AI Diagnostics CEO Thomas Edward Schoenherr reports $188,580 Tempus AI common share sale

Tempus AI wins FDA clearance for ECG software flagging pulmonary hypertension signs

Tempus AI, Inc. stock surges 75% but flashes deep overbought signals

How Far Has AI Come in Treating Diseases?

Tempus AI CFO James William Rogers disposes of USD 2.7 million in common shares

Tempus AI director Nadja West disposes of 3,000 common shares worth $161,700

Tempus AI CEO Data Ryan Fukushima disposes of 20.000 shares worth $1 juta

US Stock Market Pre-market Highlights | A New Wave of Tariffs Looms? Nasdaq Futures Rise Over 1%, TSMC Reportedly to Raise Prices by Up to 10% Next Year

Building New Foundations Amid the Ruins of the Old Order: Letter to Investors from the Flagship Product Scottish Mortgage Investment Trust of Baillie Gifford

Hims and Hers Expands Consumer-Focused Digital Health Platform

Is Tempus AI, Inc. (TEM) A Good Stock To Buy Now?

AI-Powered Tempus Inks New Multi-Year Merck Deal

TEM vs. ILMN: Which MedTech Stock Offers Greater Upside?

Cathie Wood Is Buying The Tempus AI Dip, Ark Snaps Up Stock Worth $11 Million

AI-Driven Innovation Accelerates Tempus AI's Expansion Across MedTech

Tempus AI Stock Jumps As Mizuho Starts Coverage, Earnings Scheduled For Next Week

Latest Ratings from Top Wall Street Analysts: Shopify and eBay Upgraded

Cathie Wood Goes Bargain Hunting on These Beaten-Down Tech Stocks

Temtum Price Compresses at Critical Support as RSI Rebounds, Chart Eyes $144 Breakout

Cathie Wood’s Ark Invest goes all in on AI stock